Angela Guo

1.5k total citations · 2 hit papers
27 papers, 974 citations indexed

About

Angela Guo is a scholar working on Epidemiology, Dermatology and Parasitology. According to data from OpenAlex, Angela Guo has authored 27 papers receiving a total of 974 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Epidemiology, 6 papers in Dermatology and 6 papers in Parasitology. Recurrent topics in Angela Guo's work include Herpesvirus Infections and Treatments (14 papers), Virology and Viral Diseases (6 papers) and Bartonella species infections research (5 papers). Angela Guo is often cited by papers focused on Herpesvirus Infections and Treatments (14 papers), Virology and Viral Diseases (6 papers) and Bartonella species infections research (5 papers). Angela Guo collaborates with scholars based in United States, Uganda and France. Angela Guo's co-authors include Kathleen Dooling, Grace M. Lee, Rafael Harpaz, Manisha Patel, Edward A. Belongia, Kelly L. Moore, Susannah L. McKay, Steven A. Pergam, Tara C. Anderson and Andrew J. Leidner and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Internal Medicine and Clinical Infectious Diseases.

In The Last Decade

Angela Guo

27 papers receiving 930 citations

Hit Papers

Recommendations of the Advisory Committee on Immunization... 2018 2026 2020 2023 2018 2022 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Recommendations of the Advisory Committee on Immunization Practices for Use of Herpes Zoster Vaccines
    2018 434 citations Kathleen Dooling, Angela Guo et al. MMWR Morbidity and Mortality Weekly Report profile →
  2. Use of Recombinant Zoster Vaccine in Immunocompromised Adults Aged ≥19 Years: Recommendations of the Advisory Committee on Immunization Practices — United States, 2022
    2022 133 citations Tara C. Anderson, Nina B. Masters et al. MMWR Morbidity and Mortality Weekly Report profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Angela Guo United States 11 717 199 182 166 163 27 974
Yi Luo United States 18 770 1.1× 130 0.7× 120 0.7× 686 4.1× 286 1.8× 72 1.5k
B. Ultsch Germany 18 527 0.7× 123 0.6× 114 0.6× 88 0.5× 138 0.8× 48 782
Bruno Lewin United States 16 244 0.3× 42 0.2× 45 0.2× 672 4.0× 233 1.4× 67 1.2k
Annelie Plentz Germany 19 191 0.3× 103 0.5× 249 1.4× 908 5.5× 29 0.2× 38 1.1k
Barbara Pahud United States 14 292 0.4× 28 0.1× 35 0.2× 264 1.6× 133 0.8× 36 616
Silja Bühler Switzerland 15 226 0.3× 44 0.2× 11 0.1× 234 1.4× 69 0.4× 42 724
Charles T. Leach United States 18 618 0.9× 23 0.1× 34 0.2× 397 2.4× 21 0.1× 36 1.4k
Gaby Smits Netherlands 18 522 0.7× 42 0.2× 10 0.1× 279 1.7× 269 1.7× 38 860
S. Cameron United Kingdom 23 945 1.3× 63 0.3× 24 0.1× 411 2.5× 16 0.1× 43 1.4k
C. M. Koropchak United States 19 1.0k 1.4× 254 1.3× 126 0.7× 55 0.3× 7 0.0× 27 1.3k

Countries citing papers authored by Angela Guo

Since Specialization
Citations

This map shows the geographic impact of Angela Guo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Angela Guo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Angela Guo more than expected).

Fields of papers citing papers by Angela Guo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Angela Guo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Angela Guo. The network helps show where Angela Guo may publish in the future.

Co-authorship network of co-authors of Angela Guo

This figure shows the co-authorship network connecting the top 25 collaborators of Angela Guo. A scholar is included among the top collaborators of Angela Guo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Angela Guo. Angela Guo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jones-Jack, Nkenge, Ruth Link‐Gelles, Abdulhakeem Abayomi Olorukooba, et al.. (2024). Advancing public health informatics during the COVID-19 pandemic: Lessons learned from a public–private partnership with pharmacies. Vaccine. 42. 125667–125667. 2 indexed citations
2.
Stone, Nimalie D., Amy Parker Fiebelkorn, Angela Guo, et al.. (2024). Challenges and opportunities during the COVID-19 vaccination efforts in long-term care. Vaccine. 42. 125554–125554. 1 indexed citations
3.
Wang, Xicheng, Yanhong Deng, Yanqiao Zhang, et al.. (2024). Encorafenib and cetuximab versus irinotecan/cetuximab or FOLFIRI/cetuximab in Chinese patients with BRAF V600E mutant metastatic colorectal cancer: The NAUTICAL CRC study.. Journal of Clinical Oncology. 42(17_suppl). LBA3559–LBA3559. 1 indexed citations
4.
Guo, Angela, Jessica Leung, Tracy Ayers, et al.. (2023). Mumps vaccine effectiveness of a 3rd dose of measles, mumps, rubella vaccine in school settings during a mumps outbreak -- Arkansas, 2016-2017. Public Health in Practice. 6. 100404–100404. 1 indexed citations
5.
Do, Quynh, et al.. (2023). Tracking the Metabolic Fate of Exogenous Arachidonic Acid in Ferroptosis Using Dual-Isotope Labeling Lipidomics. Journal of the American Society for Mass Spectrometry. 34(9). 2016–2024. 1 indexed citations
6.
Leidner, Andrew J., Tara C. Anderson, Ismael R. Ortega‐Sanchez, et al.. (2022). Cost-Effectiveness Analysis of Vaccination With Recombinant Zoster Vaccine Among Hematopoietic Cell Transplant Recipients and Persons With Other Immunocompromising Conditions Aged 19 to 49 Years. Value in Health. 26(2). 204–215. 4 indexed citations
7.
Hurley, Laura P., Sean T. O’Leary, Kathleen Dooling, et al.. (2022). Survey of Physician Practices, Attitudes, and Knowledge Regarding Recombinant Zoster Vaccine. Journal of General Internal Medicine. 38(4). 986–993. 12 indexed citations
8.
Guo, Angela, Nilesh Chande, Jamie Gregor, et al.. (2022). High oncostatin M predicts lack of clinical remission for patients with inflammatory bowel disease on tumor necrosis factor α antagonists. Scientific Reports. 12(1). 1185–1185. 26 indexed citations
9.
Anderson, Tara C., Nina B. Masters, Angela Guo, et al.. (2022). Use of recombinant zoster vaccine in immunocompromised adults aged ≥19 years: Recommendations of the Advisory Committee on Immunization Practices—United States, 2022. American Journal of Transplantation. 22(3). 986–990. 8 indexed citations
10.
Gharpure, Radhika, Sarah H. Yi, Ruoran Li, et al.. (2021). COVID-19 Vaccine Uptake Among Residents and Staff Members of Assisted Living and Residential Care Communities—Pharmacy Partnership for Long-Term Care Program, December 2020–April 2021. Journal of the American Medical Directors Association. 22(10). 2016–2020.e2. 10 indexed citations
11.
Leidner, Andrew J., et al.. (2021). Insurance reimbursements for recombinant zoster vaccine in the private sector. Vaccine. 39(36). 5091–5094. 5 indexed citations
12.
13.
Pike, Jamison, et al.. (2019). 2016–2017 Arkansas mumps outbreak in a close-knit community: Assessment of the economic impact and response strategies. Vaccine. 38(6). 1481–1485. 5 indexed citations
14.
Guo, Angela, Megan C. Lindley, Laura P. Hurley, et al.. (2019). Ten years of experience with herpes zoster vaccine in primary care- how attitudes and practices have changed and what it may mean for a new zoster vaccine. Vaccine. 37(37). 5509–5512. 6 indexed citations
15.
McKay, Susannah L., Angela Guo, Steven A. Pergam, & Kathleen Dooling. (2019). Herpes Zoster Risk in Immunocompromised Adults in the United States: A Systematic Review. Clinical Infectious Diseases. 71(7). e125–e134. 82 indexed citations
16.
Prosser, Lisa A., Rafael Harpaz, Angela M. Rose, et al.. (2019). A Cost-Effectiveness Analysis of Vaccination for Prevention of Herpes Zoster and Related Complications: Input for National Recommendations. Annals of Internal Medicine. 170(6). 380–388. 46 indexed citations
17.
Dooling, Kathleen, Angela Guo, Manisha Patel, et al.. (2018). Recommendations of the Advisory Committee on Immunization Practices for use of herpes zoster vaccines. American Journal of Transplantation. 18(3). 756–762. 43 indexed citations
18.
Hurley, Laura P., Mandy A. Allison, Kathleen Dooling, et al.. (2018). Primary care physicians’ experience with zoster vaccine live (ZVL) and awareness and attitudes regarding the new recombinant zoster vaccine (RZV). Vaccine. 36(48). 7408–7414. 23 indexed citations
19.
Dooling, Kathleen, Angela Guo, Manisha Patel, et al.. (2018). Recommendations of the Advisory Committee on Immunization Practices for Use of Herpes Zoster Vaccines. MMWR Morbidity and Mortality Weekly Report. 67(3). 103–108. 434 indexed citations breakdown →
20.
Guo, Angela. (2017). Blockchain Receipts: Patentability and Admissibility in Court. eYLS (Yale Law School). 16(2). 440. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yi Luo Breakdown of academic impact, for papers by B. Ultsch Breakdown of academic impact, for papers by Bruno Lewin Breakdown of academic impact, for papers by Annelie Plentz Breakdown of academic impact, for papers by Barbara Pahud Breakdown of academic impact, for papers by Silja Bühler Breakdown of academic impact, for papers by Charles T. Leach Breakdown of academic impact, for papers by Gaby Smits Breakdown of academic impact, for papers by S. Cameron Breakdown of academic impact, for papers by C. M. Koropchak
Rankless by CCL
2026